Table 2. Cox proportional hazards analysis of overall survival in stage I-II.
HS3ST2 hypermethylation | HRa | 95% CIa | P-value | |
---|---|---|---|---|
(A) Node-positive cases | No | 1.00 | ||
(N=55) | Yes | 0.84 | 0.34–3.82 | 0.69 |
(B) Node-negative cases | No | 1.00 | ||
(N=193) | Yes | 2.12 | 1.25–3.58 | 0.005 |
Adjusted for age, sex, tumor size, adjuvant therapy, recurrence, and differentiation
HR, hazard ratio; CI, confidence interval
NSCLCs (N = 248).